Kurt E. Hersberger
Impact in
- Geriatrics and Gerontology top 0.1%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 0.1%
- Medication Adherence and Compliance
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 41
-
- Medication Adherence and Compliance 37
- Co-authors
- Isabelle Arnet (64 shared papers)Markus L. Lampert (30 shared papers)J. W. Foppe van Mil (6 shared papers)Markus Messerli (12 shared papers)Marion Schaefer (2 shared papers)Samuel Allemann (17 shared papers)R. Bruppacher (10 shared papers)R. Brian Haynes (1 shared paper)
- Journals
- International Journal of Clinical Pharmacy (13 papers)BMJ Open (6 papers)Frontiers in Pharmacology (4 papers)European Journal of Clinical Pharmacology (3 papers)Pharmacogenomics and Personalized Medicine (3 papers)
- Partner nations
- SwitzerlandAustraliaPortugal
In The Last Decade
Kurt E. Hersberger
139 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 117
- Geriatrics and Gerontology 1.2k
- Family Practice 619
- Applied Microbiology and Biotechnology 114
- Toxicology 86
- Pediatrics, Perinatology and Child Health 342
Countries citing papers authored by Kurt E. Hersberger
This map shows the geographic impact of Kurt E. Hersberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt E. Hersberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt E. Hersberger more than expected).
Fields of papers citing papers by Kurt E. Hersberger
This network shows the impact of papers produced by Kurt E. Hersberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt E. Hersberger. The network helps show where Kurt E. Hersberger may publish in the future.
Co-authors
The 25 scholars most cited alongside Kurt E. Hersberger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 211 | |
| 2 | 2013 | 200 | |
| 3 | 2018 | 181 | |
| 4 | 2018 | 178 | |
| 5 | 2014 | 159 | |
| 6 | 2015 | 103 | |
| 7 | 2018 | 86 | |
| 8 | 2016 | 86 | |
| 9 | 2010 | 85 | |
| 10 | 2013 | 82 | |
| 11 | 2016 | 66 | |
| 12 | 2007 | 59 | |
| 13 | 2014 | 59 | |
| 14 | 2016 | 51 | |
| 15 | 2013 | 48 | |
| 16 | 2010 | 47 | |
| 17 | 2019 | 43 | |
| 18 | 2006 | 38 | |
| 19 | 2019 | 34 | |
| 20 | 2006 | 34 |
About Kurt E. Hersberger
Kurt E. Hersberger is a scholar working on Geriatrics and Gerontology, Family Practice, Pediatrics, Perinatology and Child Health, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 141 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (41 papers), Medication Adherence and Compliance (37 papers), Pharmaceutical studies and practices (25 papers), Pharmacogenetics and Drug Metabolism (12 papers), Atrial Fibrillation Management and Outcomes (7 papers), Pharmaceutical Economics and Policy (6 papers), Pharmacovigilance and Adverse Drug Reactions (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). The work is most often cited by research in Geriatrics and Gerontology (1.2k citations), Family Practice (619 citations), Applied Microbiology and Biotechnology (114 citations), Toxicology (86 citations) and Pediatrics, Perinatology and Child Health (342 citations). Kurt E. Hersberger has collaborated with scholars based in Switzerland, Australia and Portugal. Frequent co-authors include Isabelle Arnet, Markus L. Lampert, J. W. Foppe van Mil, Markus Messerli, Marion Schaefer, Samuel Allemann, R. Bruppacher, R. Brian Haynes, Mitja Kos and Nejc Horvat. Their work appears in journals such as International Journal of Clinical Pharmacy, BMJ Open, Frontiers in Pharmacology, European Journal of Clinical Pharmacology and Pharmacogenomics and Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.